弥合心力衰竭患者治疗实施差距:JACC焦点研讨会2/3
本文综述了增加指南导向药物治疗(GDMT) uptake的实施干预措施,讨论了实施的障碍与促进因素,总结了实施科学的概念框架,并提出了试验设计建议。作者提出一个证据到护理的概念模型,可促进证据生成与长期实施同步进行。通过采纳实施科学原则,政策制定者、研究者和临床医生可帮助减轻心衰对患者和全球医疗系统的负担。
要点
- GDMT在心力衰竭中应用不足,有效干预措施未被制度化的现状亟待改变。
- 实施科学框架可指导缩小证据与临床实践之间的差距。
- 证据到护理概念模型有望同步生成证据并促进长期实施。
核心结论
- 采纳实施科学原则可帮助减少心衰对患者和医疗系统的全球负担。
研究设计与样本
- 本文为JACC焦点研讨会综述,综合了增加GDMT uptake的实施干预措施及相关概念框架。
主要发现
- 尽管有数十年高质量证据支持,减少心衰死亡和疾病负担的GDMT实施仍不理想。
- 缩小护理差距的方法主要集中于被证明无效的策略,而显示可改善GDMT uptake的有效干预未被采用。
临床怎么用
- 临床应关注并采用被证明能提高GDMT uptake的实施干预措施。
- 可借助实施科学概念框架优化知识转化与临床实践。
- 试验设计应考虑促进试验结束后的实施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heart failure (HF) is a leading cause of death and disability in older adults. Despite decades of high-quality evidence to support their use, guideline-directed medical therapies (GDMTs) that reduce death and disease burden in HF have been suboptimally implemented. Approaches to closing care gaps have focused largely on strategies proven to be ineffective, whilst effective interventions shown to improve GDMT uptake have not been instituted. This review synthesizes implementation interventions that increase the uptake of GDMT, discusses barriers and facilitators of implementation, summarizes conceptual frameworks in implementation science that could improve knowledge uptake, and offers suggestions for trial design that could better facilitate end-of-trial implementation. We propose an evidence-to-care conceptual model that could foster the simultaneous generation of evidence and long-term implementation. By adopting principles of implementation science, policymakers, researchers, and clinicians can help reduce the burden of HF on patients and health care systems worldwide.
引用
- Jalloh MB, Averbuch T, Kulkarni P, et al. Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3. J Am Coll Cardiol. 2023. PMID: 37532425. doi:10.1016/j.jacc.2023.05.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。